BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9140988)

  • 41. Dialysis amyloidosis with massive popliteal deposition of beta 2-microglobulin amyloid.
    Brancaccio D; Gallieni M; Padovese P; Anelli A; Coggi G; Uslenghi C
    Lancet; 1988 Oct; 2(8614):802. PubMed ID: 2901651
    [No Abstract]   [Full Text] [Related]  

  • 42. [Pathogenesis of dialysis amyloidosis].
    Gejyo F; Hasegawa S; Homma N; Maruyama H; Maruyama S; Arakawa M
    Nihon Rinsho; 1992 Jan; 50 Suppl():796-800. PubMed ID: 1578769
    [No Abstract]   [Full Text] [Related]  

  • 43. [Beta 2-microglobulin and dialysis-related amyloidosis].
    Gejyo F
    Rinsho Byori; 2001 Mar; 49(3):244-8. PubMed ID: 11307323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dialysis-related amyloidosis of the tongue.
    Yusa H; Yoshida H; Kikuchi H; Onizawa K
    J Oral Maxillofac Surg; 2001 Aug; 59(8):947-50. PubMed ID: 11474463
    [No Abstract]   [Full Text] [Related]  

  • 45. Beta-2-microglobulin: a possible new uremic toxin?
    Gejyo F; Brancaccio D
    Int J Artif Organs; 1988 Jan; 11(1):3-5. PubMed ID: 3283056
    [No Abstract]   [Full Text] [Related]  

  • 46. Beta-2-microglobulin and dialysis-related amyloidosis. Recent developments.
    Floege J; Wilks MF; Granolleras C; Shaldon S; Koch KM
    Contrib Nephrol; 1989; 74():120-6. PubMed ID: 2702128
    [No Abstract]   [Full Text] [Related]  

  • 47. Pathogenetic and diagnostic aspects of dialysis-related amyloidosis.
    Schaeffer J; Floege J; Ehlerding G; Koch KM
    Nephrol Dial Transplant; 1995; 10 Suppl 3():4-8. PubMed ID: 7494614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
    Kopeć J
    Przegl Lek; 2006; 63(7):567-72. PubMed ID: 17203811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta 2-microglobulin-related amyloidosis: where do we stand?
    Gejyo F; Arakawa M
    Nephrol Dial Transplant; 1995; 10(2):155-7. PubMed ID: 7753446
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment of beta 2-microglobulin amyloidosis by extracorporeal therapies other than haemodialysis, by medication and by surgery.
    Drüeke TB
    Nephrol Dial Transplant; 1996; 11 Suppl 2():150-3. PubMed ID: 8804018
    [No Abstract]   [Full Text] [Related]  

  • 51. Carpal tunnel syndrome and beta 2-microglobulin-related amyloidosis in chronic hemodialysis patients.
    Gejyo F; Homma N; Arakawa M
    Blood Purif; 1988; 6(2):125-31. PubMed ID: 3293616
    [No Abstract]   [Full Text] [Related]  

  • 52. Formation of amyloid-like substance from beta-2-microglobulin in vitro. Role of serum amyloid P component: a preliminary study.
    Ono K; Uchino F
    Nephron; 1994; 66(4):404-7. PubMed ID: 8015642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Long-term management of dialysis patients. II. Beta 2-microglobulin associated amyloidosis and acquired cystic kidney disease].
    Floege J; Segerer S; Schäffer J; Koch KM
    Internist (Berl); 1999 Jan; 40(1):64-9. PubMed ID: 10086302
    [No Abstract]   [Full Text] [Related]  

  • 54. beta 2-microglobulin and amyloidosis: who is at risk?
    Davison AM
    Nephrol Dial Transplant; 1995; 10 Suppl 10():48-51. PubMed ID: 8825433
    [No Abstract]   [Full Text] [Related]  

  • 55. Dialysis arthropathy, amyloidosis and beta-2 microglobulin.
    Cameron JS
    Pediatr Nephrol; 1987 Apr; 1(2):224-9. PubMed ID: 3153281
    [No Abstract]   [Full Text] [Related]  

  • 56. [Contribution of Japanese researchers to progress in studies on nephrology in the past 100 years: Beta2-microglobulin as an etiological factor of amyloidosis in patients undergoing hemodialysis].
    Gejo F
    Nihon Naika Gakkai Zasshi; 2002 May; 91(5):1434-6. PubMed ID: 12082730
    [No Abstract]   [Full Text] [Related]  

  • 57. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
    Saito A; Gejyo F
    Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dialysis related amyloidosis.
    Bardin T
    J Rheumatol; 1987 Aug; 14(4):647-9. PubMed ID: 3312600
    [No Abstract]   [Full Text] [Related]  

  • 59. Performance of the newer type (Lixelle Type S-15) on direct hemoperfusion beta-2-microglobulin adsorption column for dialysis-related amyloidosis.
    Hiyama E; Hyodo T; Kondo M; Otsuka K; Honma T; Taira T; Yoshida K; Uchida T; Endo T; Sakai T; Baba S; Hidai H
    Nephron; 2002 Oct; 92(2):501-2. PubMed ID: 12218344
    [No Abstract]   [Full Text] [Related]  

  • 60. Survey of the effects of a column for adsorption of β2-microglobulin in patients with dialysis-related amyloidosis in Japan.
    Gejyo F; Amano I; Ando T; Ishida M; Obayashi S; Ogawa H; Ono T; Kanno Y; Kitaoka T; Kukita K; Kurihara S; Sato M; Shin J; Suzuki M; Takahashi S; Taguma Y; Takemoto Y; Nakazawa R; Nakanishi T; Nakamura H; Hara S; Hiramatsu M; Furuya R; Masakane I; Tsuchida K; Motomiya Y; Morita H; Yamagata K; Yoshiya K; Yamakawa T;
    Ther Apher Dial; 2013 Feb; 17(1):40-7. PubMed ID: 23379492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.